Photocure ASA (($PHCUF)) announced an update on their ongoing clinical study. The Blue Light Cystoscopy With Cysview® Registry study, officially ...

Credit: Getty Images. 5α-reductase inhibitors are widely used to treat lower urinary tract symptoms in men with benign prostatic hyperplasia. Use of 5α-reductase inhibitors (5-ARIs) prior to a bladder ...

Urogen Pharma (($URGN)) announced an update on their ongoing clinical study. Study Overview: UroGen Pharma is conducting a Phase 3 study titled ‘A ...

Purpose: We investigated the feasibility, safety, and biologic activity of adenovirus-mediated p53 gene transfer in patients with locally advanced bladder cancer. Results: Thirteen patients received a ...

INVEST: A phase Ib window of opportunity study of atezolizumab administered either intravesically or direct tumour injection in patients with bladder cancer prior to radical cystectomy. This is an ...

In recent years the management of non-muscle-invasive bladder cancer has undergone radical changes. Intravesical Bacillus Calmette-Guérin (BCG) has long been established as the therapeutic standard ...

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to building and commercializing novel solutions that treat urothelial and specialty cancers, ...

PRINCETON, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative treatments for urothelial and specialty ...

If you're among the millions of women suffering from interstitial cystitis, a bladder disorder characterized by intense discomfort, you may have struggled for years to find the right treatment. For ...

Potential to transform care and access to treatment for this growing patient population PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen Pharma Ltd. (Nasdaq: URGN), a biopharmaceutical company dedicated to ...